Publications

American journal of human genetics

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

03-01-2019

Journal of community genetics

Clinicians' use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey.

01-01-2019

Oncoimmunology

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival.

14-12-2018

Journal of the National Cancer Institute

Targeting Exercise Interventions to Patients With Cancer in Need: An Individual Patient Data Meta-Analysis.

01-11-2018

Public health genomics

Recall and Retention of Consent Procedure Contents and Decisions: Results of a Randomized Controlled Trial.

11-09-2018

European journal of cancer (Oxford, England : 1990)

Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.

01-09-2018

International journal of cancer

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

15-08-2018

Nature genetics

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.

01-07-2018

Drug and alcohol dependence

Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use.

01-07-2018

European journal of cancer (Oxford, England : 1990)

Corrigendum to "An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint^®)" [Eur J Cancer 75 (April 2017) 5-13].

01-06-2018

Annals of surgery

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.

01-05-2018

Human mutation

The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.

01-05-2018

Scientific reports

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

26-04-2018

International journal of epidemiology

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.

01-04-2018

Genetic testing and molecular biomarkers

Patients' Attitudes Towards the Return of Incidental Findings After Research with Residual Tissue: A Mixed Methods Study.

01-03-2018

BMC cancer

The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors.

27-02-2018

Oncotarget

Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.

26-12-2017

PloS one

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

22-12-2017

International journal of epidemiology

Body mass index and breast cancer survival: a Mendelian randomization analysis.

01-12-2017

Nature genetics

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

01-12-2017

Oncotarget

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.

28-11-2017

BMJ open

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.

14-11-2017

Breast cancer research : BCR

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.

07-11-2017

Nature

Association analysis identifies 65 new breast cancer risk loci.

02-11-2017

International journal of cancer

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.

01-11-2017

Breast cancer research and treatment

The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study.

01-11-2017

Diabetologia

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.

01-09-2017

Journal of the National Cancer Institute

Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.

01-08-2017

Primary care diabetes

Trends in breast cancer incidence among women with type-2 diabetes in British general practice.

01-08-2017

European journal of cancer (Oxford, England : 1990)

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.

01-06-2017

Nature genetics

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

01-06-2017

Cancer research

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

01-06-2017

BMC public health

The role of Indonesian patients' health behaviors in delaying the diagnosis of nasopharyngeal carcinoma.

25-05-2017

Breast cancer research : BCR

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.

22-05-2017

Genetics in medicine : official journal of the American College of Medical Genetics

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

01-05-2017

European journal of cancer (Oxford, England : 1990)

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint^®).

01-04-2017

Oncotarget

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

14-03-2017

Breast cancer research : BCR

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.

09-03-2017

Nature

Rare and low-frequency coding variants alter human adult height.

09-02-2017

PloS one

Diabetes and Breast Cancer Subtypes.

12-01-2017

Breast cancer research and treatment

Erratum to: Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.

01-01-2017

Cancer treatment reviews

Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs.

01-01-2017

Oncotarget

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.

06-12-2016

Journal of medical genetics

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

01-12-2016

Scientific reports

rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk.

15-11-2016

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Consensus opinion on MRI simulation for external beam radiation treatment planning.

01-11-2016

Breast cancer research : BCR

Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.

18-10-2016

American journal of human genetics

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.

06-10-2016

Breast cancer research : BCR

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.

03-10-2016

Breast cancer research and treatment

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.

01-10-2016

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

Clinicians' use of breast cancer risk assessment tools according to their perceived importance of breast cancer risk factors: an international survey.

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival.

Targeting Exercise Interventions to Patients With Cancer in Need: An Individual Patient Data Meta-Analysis.

Recall and Retention of Consent Procedure Contents and Decisions: Results of a Randomized Controlled Trial.

Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.

Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use.

Corrigendum to "An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®)" [Eur J Cancer 75 (April 2017) 5-13].

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.

The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium.

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium.

Patients' Attitudes Towards the Return of Incidental Findings After Research with Residual Tissue: A Mixed Methods Study.

The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors.

Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.

Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.

Body mass index and breast cancer survival: a Mendelian randomization analysis.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.

Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.

Association analysis identifies 65 new breast cancer risk loci.

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.

The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study.

Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.

Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.

Trends in breast cancer incidence among women with type-2 diabetes in British general practice.

Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years.

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

The role of Indonesian patients' health behaviors in delaying the diagnosis of nasopharyngeal carcinoma.

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®).

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.

Rare and low-frequency coding variants alter human adult height.

Diabetes and Breast Cancer Subtypes.

Erratum to: Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.

Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs.

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk.

Consensus opinion on MRI simulation for external beam radiation treatment planning.

Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.

This site uses cookies

Corrigendum to "An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint^®)" [Eur J Cancer 75 (April 2017) 5-13].

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint^®).